Our services are specially designed for and exclusively offered to individuals with respect to disabilities adversely impacted by fragrances and scents.
- Multiple Chemical Sensitivity
- Myalgic Encephalomyelitis
- Fibromyalgia
- Asthma
- Autism
- Allergies
- COPD
- Migraines
- And More
Multiple Chemical Sensitivities
A medical disability that triggers symptoms upon exposure to chemicals in commonly used products, impacting 1 in 34 Canadians.
More than 1 million Canadians aged 12 years and above have a medical diagnosis of Multiple Chemical Sensitivity.
This Represents 3.5% of the Canadian population.
72% of Canadians diagnosed with Multiple Chemical Sensitivity are women.
Around 72% of people diagnosed with Multiple Chemical Sensitivity are over the age off 55.
(Statistics Canada 2020)Using nationally representative population samples across four countries, data were collected in June 2016 and June 2017.
Results found that, across the four countries:
Chemical sensitivity is widespread across the four countries, affecting over 61 million people.
19.9% of the population report chemical sensitivity, and 32.2% report fragrance sensitivity.
26.0% of the population report asthma/asthma-like conditions, of which 42.6% report chemical sensitivity and 57.8% fragrance sensitivity
4.5% of the population report autism/ASDs, of which 60.6% report chemical sensitivity and 75.8% fragrance sensitivity.
Among individuals with chemical sensitivity, 55.4% also report asthma/asthma-like conditions, 13.5% autism/ASDs, and 82.0% fragrance sensitivity.
For 44.1% of individuals with chemical sensitivity, the severity of health effects from fragranced products can be potentially disabling.
28.6% of those with chemical sensitivity have lost workdays or a job, in the past year, due to exposure to fragranced products in the workplace.
Vulnerable individuals such as those with asthma and autism are especially affected.
Fragranced consumer products can contribute to the adverse health, economic, and societal effects.